Saturday, June 27, 2026

Classys Unveils Aggressive Growth Strategy at AAD 2026: What’s Next for the U.S. Market?

Classys reveals its growth strategy for the U.S. market at AAD 2026, showcasing innovative products and emphasizing clinical efficacy.

Kim Jong Un’s Direct Intervention: A Lifeline for Flood Victims

Rodong Sinmun reported that Kim Jong Un mobilized helicopters to rescue over 4,200 residents isolated by flooding.

“The Envoy of WWIII?”: Trump’s Hardline Nominee Michelle Steel Arrives on a Collision Course with Seoul

Michelle Park Steel's nomination as U.S. ambassador to South Korea raises hopes and concerns over her stance on China and North Korea.

Tag: Leclaza

NCCN Endorses Leclaza and Rybrevant Combo as Top Lung Cancer Treatment: What You Need to Know

NCCN guidelines now classify Leclaza + Rybrevant as a preferred first-line treatment for lung cancer, enhancing patient access and management.

Top News

- Our Sponsors Ad -

Follow us